Open AccessBerberine Can Target the VEGFR2/ERK Pathway to Inhibit Angiogenesis in Glioblastoma Xenografts
Author(s) -
Huaze Liu
Publication year - 2022
Publication title -
proceedings of the 11th international conference on biomedical engineering and bioinformatics
Language(s) - English
Resource type - Conference proceedings
DOI - 10.5220/0011313500003443
Subject(s) - angiogenesis , glioblastoma , vegf receptors , mapk/erk pathway , cancer research , berberine , computer science , medicine , signal transduction , microbiology and biotechnology , biology , pharmacology